A significant number of proteins in both eukaryotes and prokaryotes are known to be post-translationally modified by the addition of phosphate, serving as a means of rapidly regulating protein function. Phosphorylation of the amino acids serine, threonine and tyrosine are the focus of the vast majority of studies aimed at elucidating the extent and roles of such modification, yet other amino acids, including histidine and aspartate, are also phosphorylated. Although histidine phosphorylation is known to play extensive roles in signalling in eukaryotes, plants and fungi, roles for phosphohistidine are poorly defined in higher eukaryotes. Characterization of histidine phosphorylation aimed at elucidating such information is problematic due to the acid-labile nature of the phosphoramidate bond, essential for many of its biological functions. Although MSbased strategies have proven extremely useful in the analysis of other types of phosphorylated peptides, the chromatographic procedures essential for such approaches promote rapid hydrolysis of phosphohistidinecontaining peptides. Phosphate transfer to non-biologically relevant aspartate residues during MS analysis further complicates the scenario.
Histidine phosphorylation in biological systems
In prokaryotes, fungi and plants, histidine kinase function is well documented. Targeted analyses in these organisms have demonstrated that autophosphorylation of transmembrane histidine kinases initiates a 'two-component' intracellular signalling system in conjunction with phosphorylation of defined aspartate residues. Together, these modifications act as part of a signalling system that allows these organisms to respond rapidly to changes in a multitude of environmental conditions (for detailed reviews, see [1] [2] [3] ). In contrast, mammalian systems rely on transmembrane tyrosine kinase receptors to initiate similar responses to external stimuli, and studies characterizing the role of histidine phosphorylation in these cells are very rare. Remarkably, phosphorylation of histidine is reported to comprise up to 6% of the total phosphoamino acid content in nuclear extracts of model eukaryotes, which is significantly greater than the typical abundance of phosphorylated tyrosine [4] , but the amount of phosphohistidine in the cytoplasm has yet to be assessed. Although histidine phosphorylation in mammalian cells was first reported over 50 years ago [5] , wide-scale characterization of this reversible modification in human cells is still lacking. This is in large part due to the inherent instability of phosphorylated histidine under acidic conditions and at elevated temperature [6, 7] , typical conditions used in most biochemical and proteomic analyses. Higher eukaryotes are known to contain kinases and phosphatases that control the reversible phosphorylation of histidine residues, yet primary sequence analysis indicates that these organisms do not possess homologues of the 'two-component' systems described above [8] . Evidence acquired by functional characterization of individual proteins suggests the involvement of phosphohistidine in mammalian cell signalling, both by virtue of functioning as a catalytic intermediate in phosphotransfer reactions [5, [9] [10] [11] [12] [13] [14] and as a reversibly regulated moiety that regulates protein structure and thus function [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] , akin to the more widely characterized phosphorylation-induced regulation. Specifically, HHK (histone H4 histidine kinase) activity has been reported in a wide range of cell types and is often associated with cell growth and development. For example, although basal HHK activity is relatively low in liver progenitor cells, mechanical and/or chemical damage induces HHK activity, triggering hepatocyte proliferation and/or differentiation [16, 26, 27] . Moreover, mutation studies have indicated a role for the histidine kinase activity of Nm23-H1, an NDPK (nucleoside diphosphate kinase), in the suppression of tumour metastasis [28, 29] . Phosphorylation of histidine has been implicated further in the differentiation of PC12 neuronal cells, with NGF (nerve growth factor), but not EGF (epidermal growth factor), inducing a 3-fold increase in the level of histidine kinase activity against an exogenous substrate [30] . T-cell signalling is also influenced, with the histidine kinase NDPK-B having been shown to regulate T-cell receptor-stimulated flux through the K + channel KCa3.1 as a result of histidine phosphorylation of the protein C-terminus [23] . Nme2 (NDPK-B) − / − mice have defects in KCa3.1 channel function and cytokine production from T helper cells, supportive of a role for histidine phosphorylation in T-cell signalling [31] . An additional role for histidine phosphorylation has been implicated in glycoprotein VI signalling in platelets [14] and also bone remodelling [32] through the novel histidine tyrosine phosphatase TULA-2 (T-cell ubiquitin ligand 2) which contains a conserved phosphohistidine residue within its catalytic core: mice lacking a functional enzyme have increased osteoclast function. Moreover, Rasdependent histidine phosphorylation of a 38 kDa protein from rat liver plasma membrane is differentially regulated during cell division [33] .
Given this accumulating evidence of a role for histidine phosphorylation in cell signalling in vertebrates, a large-scale unbiased study to identify such sites of modification and assess the scale of histidine phosphorylation in higher eukaryotes, rather than phosphohistidine site identification through serendipitous discoveries, is essential. If the working hypothesis of a role for phosphohistidine in vertebrate cell signalling is correct, analogous to its role in regulating cellular signalling in bacteria, plants and fungi, profiling this modification on a global scale could revolutionize studies in vertebrate/mammalian signal transduction pathways. On the basis of current, albeit limited, evidence, phosphorylation of histidine has the potential to be as important in vertebrate cell signalling as phosphorylation of serine, threonine and tyrosine residues. Determining the extent and sites of histidine phosphorylation is thus essential to ultimately define the roles and mechanisms of regulation. Protein kinases are the second most popular protein family targeted in pharmaceutical drug discovery, and should histidine phosphorylation be aberrant under disease conditions, identification and characterization of the relevant histidine kinase(s) will be essential for these enzymes to be exploited as potentially extremely attractive drug targets.
Biochemical tools for the analysis of histidine phosphorylation
Classical methods used in the analysis of serine, threonine and tyrosine phosphorylation, such as trichloroacetic acid precipitation [34] and amino acid analysis (used to define the type of modified residue) [35] , are ineffective for studying phosphohistidine, as the free energy for hydrolysis of the phosphoramidate bond (P-N) is more negative than for the P-O bond of phosphoester amino acids [36] , making it acid-labile. Two rapidly interconverting regioisomers, π -phosphohistidine and τ -phosphohistidine (Figure 1 ), have been described, with the former rapidly isomerizing to the latter under basic conditions [6] . Along with the intrinsic instability of phosphohistidine at low pH, dephosphorylation of this residue by nucleophilic attack has also been described, complicating the scenario further.
More specific methods for identifying phosphohistidinecontaining polypeptides, which take account of this instability, have been introduced. Wei and Matthews [37] developed a membrane-based method for the detection of alkali-stable protein phosphorylation enabling analysis of histidine phosphorylated proteins. Fujitaki and Smith [38] described a strategy for the detection of phosphoramidatecontaining proteins by 31 P-NMR. However, such currently available methods for studying histidine phosphorylated proteins are not appropriate for large-scale analysis as they require characterization on a protein-by-protein basis. Moreover, both of these methods are relatively insensitive, with NMR analysis requiring nanomolar amounts of purified material. The number of potential sites of phosphohistidine in human systems is therefore impossible to estimate at the present time. Development of generic antibodies against phosphohistidine (analogous to those successfully raised against phosphotyrosine [39] ), would permit enrichment of phosphohistidine-containing proteins, aiding further characterization, yet attempts by us and others have so far been unsuccessful. This is presumably due to the instability of the phosphoramidate bond and/or the comparatively small epitope size. Additionally, no strong consensus motifs for phosphohistidine have yet been identified, which might aid the design of better immunogens. Although there does appear to be a requirement for a lysine residue at position + 2, C-terminal to the site of modification [40] , there is need for a consensus motif to be clearly defined. Such a motif would help to predict further putative sites of modification and aid the development of essential immunochemical tools for analysis. The synthesis of peptides containing stable, non-hydrolysable, non-isomerizable triazole phosphonate analogues of phosphohistidine [41, 42] has demonstrated utility for the generation of a site-specific phosphohistidine antibody against His 18 on histone H4 [43] , and antigens containing this mimic may yet prove useful for the development of more generic phosphohistidine antibodies.
MS for the analysis of histidine phosphorylation: challenges and possible solutions
MS-driven analyses have been invaluable in characterizing sites of phosphoserine, phosphothreonine and phosphotyrosine, both on specific proteins and also in largescale proteomics studies [44] [45] [46] [47] [48] [49] [50] [51] . A typical workflow in 'bottom-up' phosphoproteomics entails digestion of the protein or mixture of proteins into peptides, either enzymatically or chemically. Owing to their relatively low abundance, arising from the often substoichiometric nature of phosphorylation, combined with their reduced ionization efficiency, phosphorylated peptides are normally enriched before LC (liquid chromatography)-MS analysis to increase the chances of detection [52] . Phosphopeptide enrichment is usually accomplished by selectively binding phosphopeptides to metal oxides such as TiO 2 [53, 54] , thus exploiting the ability of the phosphate to co-ordinate the positively charged metal. This procedure is normally performed under acidic conditions to increase the selectivity of binding and is therefore less than ideal for application to histidine-phosphorylated peptides, as the modification might be lost during enrichment. Several attempts have been reported for the enrichment of phosphohistidine-containing peptides using modified versions of available protocols, including the application of IMAC (immobilized metalion-affinity chromatography) with Cu(II) [as opposed to the more commonly employed Fe(III)] to the enrichment of histidine-phosphorylated peptides following digestion of HPr (histidine-containing phosphocarrier protein) with protease V8 [55] . However, these procedures have yet to demonstrate utility in a global analysis of phosphohistidine.
Large-scale phosphoproteomics studies are typically performed in positive-ion mode, where the charges on the peptides are provided by the ionizing protons. Under these conditions, the acid-labile nature of phosphohistidine makes its detection by standard LC-MS methodologies rather challenging. The half-life of the phosphoramidate bond in phosphohistidine-containing peptides has been estimated to be approximately 30 min at pH 3 [56] , and studies of phosphohistidine stability in different contexts (intact protein compared with V8-generated peptides) has revealed altered phosphohistidine stability dependent on localized structure. Nonetheless, these studies demonstrate how most of the signal related to these species is likely to be lost during the prolonged chromatographic procedures required for analysis, leading to a reduced amount of analyte eventually reaching the MS detector. Shorter chromatographic gradients with acidic buffers have been explored for limiting the acidinduced hydrolysis of phosphohistidine during the LC-MS analysis [57] . However, this approach is limited by the complexity of the sample, as pre-fractionation and/or longer gradients are usually required for optimal chromatographic separation of more complex mixtures of peptides. These authors also considered neutral and basic buffers for LC; however, perhaps unsurprisingly, they noticed a decrease in the MS signal intensity and a loss of chromatographic resolution. Although the studies described above have succeeded in identifying histidine-phosphorylated peptides, each to different extents, it should be noted that the analysis was performed on recombinant in vitro phosphorylated proteins, therefore providing the authors with starting amounts of material that are significantly greater than could be obtained from a biological sample. MS analysis in negative-ion mode has also been explored as an alternative to standard instrumental conditions [58] , with reduced neutral loss of the phosphate (and thus increased likelihood of site identification) being observed in negative-ion, rather than positive-ion, MALDI (matrix-assisted laser-desorption ionization)-MS analysis.
Phosphate transfer
Whereas the acid-labile nature of phosphohistidine constitutes a severe limitation to its characterization, it is also responsible for the occurrence of the phosphate transfer from the histidine to an acceptor residue (such as aspartate) on the same or a different polypeptide. This intra-or intermolecular process, which is likely to be controlled by general acid catalysis, not only occurs in cells, but also can happen in solution as indicated by studies in our laboratory, for example during sample storage or even over the timescale of an LC-MS experiment. To test the conditions and prevalence of this transfer, we used a synthetic peptide containing both aspartate and histidine residues (DAPAHDAKD), and performed phosphorylation of the histidine residue with potassium phosphoramidate (KHPO 3 NH 2 ) in water at pH 8. The reaction, described to be regioselective [37] , resulted exclusively in histidine phosphorylation, as confirmed by CID (collision-induced dissociation)-tandem MS analysis of the corresponding doubly protonated peptide at m/z 510.1 (Figure 2 ).
The same peptide was then analysed by nUPLC (nano-ultraperformance liquid chromatography)-nESI (nano-electrospray ionization)-tandem MS, using 50 mM ammonium acetate at neutral pH for the chromatographic gradient, but loading the peptide solution under acidic conditions to improve peptide trapping (pH 2). The extracted ion chromatogram of m/z 510.1 showed two distinct resolved chromatographic peaks ( Figure 3A) , the identity of which was confirmed by manual interrogation of the CID product ion mass spectra of the corresponding precursor ions as DAPAHpDAKD (10.9 min; Figure 3B ) and DAPApHDAKD (11.6 min). The generation of this aspartate-phosphorylated peptide demonstrates that transfer of the phosphate moiety from the modified histidine residue to an acceptor aspartate residue can occur as an experimental artefact (i.e. during the time course of a relatively short LC-MS analysis), apparently in a non-specific manner. Such phosphate transfer leads to the generation of a modified peptide with the same mass (and m/z) as that of the original sequence, therefore making the two species indistinguishable by MS alone, although tandem MS can be used to differentiate between the two species. In our experience, the extent of this phosphate transfer is hard to predict, being highly dependent not only on the solution conditions and sample handling, but also on the localized environment of the donor and acceptor sites. Although it may be possible to account for the product of such non-specific phosphate transfer when analysing a relatively simple mixture of peptides by manual inspection of raw data, potentially acquired under conditions where phosphate transfer is more or less likely to result, a large-scale study will require highthroughput sample processing and inevitably rely on the use of automated search engines. Should the transfer of phosphate from a histidine to an aspartate residue occur during this type of analysis, modified aspartate residues could be identified that are not biologically relevant.
The instability of phosphohistidine at low pH also has consequences at earlier stages in a standard MS workflow. Analogous to the on-line chromatography, the desalting procedures essential for sample clean-up often rely on the binding of the peptides to C 18 stationary phases under acidic conditions; such sample treatment is essential to reduce the amount of salts and other low-molecular-mass species whose presence would complicate the analysis and typically result in signal suppression. Comparison of different desalting strategies using C 18 reverse-phase at pH 2 before LC-MS analysis as above (pH 7), either off-line or on-line over a period of 60 min, demonstrated a differential effect of the rate of phosphoramidate loss for the two synthetic histidinephosphorylated peptides tested: GVLGpHDLGNP and DAPApHDAKD. The ratio of the MS signal intensity between the phosphorylated and hydrolysed species fell significantly for GVLGpHDLGNP following both the 60 min on-line wash (87% of hydrolysis) and the off-line C 18 desalting (83% of hydrolysis). However, whereas hydrolysis was complete for DAPApHDAKD as a result of the 60 min on-line wash, phosphohistidine hydrolysis was minimal (15%) for the off-line desalting procedure (results not shown). Although it is difficult to draw conclusions on the basis of such a limited dataset, it is clear from these results that major sample losses due to acid-induced hydrolysis can be experienced at all stages during phosphoproteomics analysis, making the detection of histidine-phosphorylated peptides extremely challenging. 
Conclusions
Despite the largely recognized role of histidine phosphorylation in a myriad of biological systems, both as catalytic intermediates and as molecular switches for regulating protein function, the analysis of this important post-translational modification has been limited due to the lack of suitable chemical and biochemical tools for its detection and quantification. The instability of phosphohistidine poses severe limitations to the generation of phosphospecific antibodies, although the use of more stable analogues for the synthesis of optimized epitopes is starting to show some potential.
Despite the versatility and sensitivity of LC-MS analysis, particularly for sites of post-translational modification, the analysis of histidine phosphorylation faces major challenges arising from the essential acid-labile nature of the phosphoramidate bond. Sample loss due to hydrolysis of the phosphorylated peptides, along with the occurrence of phosphate transfer from histidine to aspartate residues during sample preparation and analysis are among the most relevant issues, especially if a large-scale phosphohistidine analysis is to be undertaken. Furthermore, given our observations of non-specific in vitro transfer of the phosphate group from histidine to aspartate, the future of phosphoaspartate analysis is likely to be even more problematic.
Our group and others have attempted to develop methods for the high-throughput characterization of such analytes, but much work is still required. Continuous advances in the field, mainly focusing on sample processing and chromatographic separation at the peptide level, and optimally the development of suitable enrichment procedures will undoubtedly improve the MS-based analysis of histidine phosphorylation. 
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